Covid: UK Health Secretary Agency says seeing evidence of immune evasion with Omicron

According to the UK Health Secretary Agency, there is evidence of immune evasion with the Omicron Covid-19 variant, according to Reuters. The agency said that two experiments show Omicron to have decreased lab neutralisation by 20 to 40 fold compared to the original virus, and by 10 to 20 fold compared to the Delta variant.

The agency added that the booster increases protection against mild disease to around 70-75% in a real-world study looking at 581 people with confirmed Omicron infection. However, the agency said that it was seeing reduced vaccine effectiveness for both the AstraZeneca and Pfizer jabs against mild disease with Omicron. 

Market Reaction

Markets did not react to the latest data from the UK Health Secretary Agency. 

USD/CHF Price Analysis: Testing an upslope trendiline around 0.9200-05, after US inflation figures

On Friday, after the US Labor Department reported that US CPI rose to the highest level since 1982, the USD/CHF edges down 0.32%, trading at 0.9206 du
Mehr darüber lesen Previous

S&P 500 pushes higher, eyes 4700 again amid “relief” that high US inflation wasn’t even higher

US equities gained across the board amid relief that the November US Consumer Price Inflation (CPI) report didn’t again surprise on the upside. The S&
Mehr darüber lesen Next